BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 30450290)

  • 1. Breath analysis as a diagnostic and screening tool for malignant pleural mesothelioma: a systematic review.
    Brusselmans L; Arnouts L; Millevert C; Vandersnickt J; van Meerbeeck JP; Lamote K
    Transl Lung Cancer Res; 2018 Oct; 7(5):520-536. PubMed ID: 30450290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breath analysis by gas chromatography-mass spectrometry and electronic nose to screen for pleural mesothelioma: a cross-sectional case-control study.
    Lamote K; Brinkman P; Vandermeersch L; Vynck M; Sterk PJ; Van Langenhove H; Thas O; Van Cleemput J; Nackaerts K; van Meerbeeck JP
    Oncotarget; 2017 Oct; 8(53):91593-91602. PubMed ID: 29207669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breath Analysis for Early Detection of Malignant Pleural Mesothelioma: Volatile Organic Compounds (VOCs) Determination and Possible Biochemical Pathways.
    Di Gilio A; Catino A; Lombardi A; Palmisani J; Facchini L; Mongelli T; Varesano N; Bellotti R; Galetta D; de Gennaro G; Tangaro S
    Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32429446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exhaled Breath Analysis in Diagnosis of Malignant Pleural Mesothelioma: Systematic Review.
    Töreyin ZN; Ghosh M; Göksel Ö; Göksel T; Godderis L
    Int J Environ Res Public Health; 2020 Feb; 17(3):. PubMed ID: 32050546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemical characterization of exhaled breath to differentiate between patients with malignant plueral mesothelioma from subjects with similar professional asbestos exposure.
    de Gennaro G; Dragonieri S; Longobardi F; Musti M; Stallone G; Trizio L; Tutino M
    Anal Bioanal Chem; 2010 Dec; 398(7-8):3043-50. PubMed ID: 20924566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exhaled breath to screen for malignant pleural mesothelioma: a validation study.
    Lamote K; Vynck M; Thas O; Van Cleemput J; Nackaerts K; van Meerbeeck JP
    Eur Respir J; 2017 Dec; 50(6):. PubMed ID: 29269578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breath Analysis: A Systematic Review of Volatile Organic Compounds (VOCs) in Diagnostic and Therapeutic Management of Pleural Mesothelioma.
    Catino A; de Gennaro G; Di Gilio A; Facchini L; Galetta D; Palmisani J; Porcelli F; Varesano N
    Cancers (Basel); 2019 Jun; 11(6):. PubMed ID: 31207975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarkers for early diagnosis of malignant mesothelioma: Do we need another moonshot?
    Lagniau S; Lamote K; van Meerbeeck JP; Vermaelen KY
    Oncotarget; 2017 Aug; 8(32):53751-53762. PubMed ID: 28881848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of malignant pleural mesothelioma in exhaled breath by multicapillary column/ion mobility spectrometry (MCC/IMS).
    Lamote K; Vynck M; Van Cleemput J; Thas O; Nackaerts K; van Meerbeeck JP
    J Breath Res; 2016 Sep; 10(4):046001. PubMed ID: 27669062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determining the clinical utility of a breath test for screening an asbestos-exposed population for pleural mesothelioma: baseline results.
    Zwijsen K; Schillebeeckx E; Janssens E; Cleemput JV; Richart T; Surmont VF; Nackaerts K; Marcq E; van Meerbeeck JP; Lamote K
    J Breath Res; 2023 Sep; 17(4):. PubMed ID: 37683624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Headspace Volatile Organic Compound Profiling of Pleural Mesothelioma and Lung Cancer Cell Lines as Translational Bridge for Breath Research.
    Janssens E; Mol Z; Vandermeersch L; Lagniau S; Vermaelen KY; van Meerbeeck JP; Walgraeve C; Marcq E; Lamote K
    Front Oncol; 2022; 12():851785. PubMed ID: 35600344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An electronic nose distinguishes exhaled breath of patients with Malignant Pleural Mesothelioma from controls.
    Dragonieri S; van der Schee MP; Massaro T; Schiavulli N; Brinkman P; Pinca A; Carratú P; Spanevello A; Resta O; Musti M; Sterk PJ
    Lung Cancer; 2012 Mar; 75(3):326-31. PubMed ID: 21924516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strengths, weaknesses, and opportunities of diagnostic breathomics in pleural mesothelioma-a hypothesis.
    Lamote K; Nackaerts K; van Meerbeeck JP
    Cancer Epidemiol Biomarkers Prev; 2014 Jun; 23(6):898-908. PubMed ID: 24706728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. External Validation of a Breath-Based Prediction Model for Malignant Pleural Mesothelioma.
    Janssens E; Schillebeeckx E; Zwijsen K; Raskin J; Van Cleemput J; Surmont VF; Nackaerts K; Marcq E; van Meerbeeck JP; Lamote K
    Cancers (Basel); 2022 Jun; 14(13):. PubMed ID: 35804954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of serum vascular endothelial growth factor in malignant pleural mesothelioma.
    Yasumitsu A; Tabata C; Tabata R; Hirayama N; Murakami A; Yamada S; Terada T; Iida S; Tamura K; Fukuoka K; Kuribayashi K; Nakano T
    J Thorac Oncol; 2010 Apr; 5(4):479-83. PubMed ID: 20357617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Regional treatment of malignant pleural mesothelioma: results from the tumor centre Regensburg].
    Ried M; Speth U; Potzger T; Neu R; Diez C; Klinkhammer-Schalke M; Hofmann HS
    Chirurg; 2013 Nov; 84(11):987-93. PubMed ID: 23743993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarkers for malignant pleural mesothelioma: current status.
    Greillier L; Baas P; Welch JJ; Hasan B; Passioukov A
    Mol Diagn Ther; 2008; 12(6):375-90. PubMed ID: 19035624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Highly Sensitive Pleural Effusion Protein Biomarkers for Malignant Pleural Mesothelioma by Affinity-Based Quantitative Proteomics.
    Palstrøm NB; Overgaard M; Licht P; Beck HC
    Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Exploratory study on the detection of markers for diagnosing early-stage malignant mesothelioma].
    Fukuoka K; Tanaka F; Tsujimura T; Hashimoto-Tamaoki T; Hasegawa S; Nakano T
    Nihon Eiseigaku Zasshi; 2011 May; 66(3):553-7. PubMed ID: 21701086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic and Prognostic Biomarkers in the Rational Assessment of Mesothelioma (DIAPHRAGM) study: protocol of a prospective, multicentre, observational study.
    Tsim S; Kelly C; Alexander L; McCormick C; Thomson F; Woodward R; Foster JE; Stobo DB; Paul J; Maskell NA; Chalmers A; Blyth KG
    BMJ Open; 2016 Nov; 6(11):e013324. PubMed ID: 27884852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.